RION, Mayo Clinic, and the U.S. Army Medical Research Institute for Chemical Defense Receive $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics

ROCHESTER, Minn.–(BUSINESS WIRE)–RION, a leading clinical-stage regenerative medicine company, today announced that it will collaborate with Mayo Clinic and the U.S. Army Medical Research Institute for Chemical Defense (ICD) on a $2.4M grant awarded from the Department of Defense. This grant accelerates a critical research initiative aimed at exploring the therapeutic potential of RION’s proprietary Purified Exosome Product™ (PEP™) for the treatment of Chronic Obstructive Pulmonary Disease (C
Click here to view original post